ATE320814T1 - Verwendung von zinkhyaluronat gegen magengeschwür - Google Patents

Verwendung von zinkhyaluronat gegen magengeschwür

Info

Publication number
ATE320814T1
ATE320814T1 AT98920684T AT98920684T ATE320814T1 AT E320814 T1 ATE320814 T1 AT E320814T1 AT 98920684 T AT98920684 T AT 98920684T AT 98920684 T AT98920684 T AT 98920684T AT E320814 T1 ATE320814 T1 AT E320814T1
Authority
AT
Austria
Prior art keywords
zinc hyaluronate
stomach ulcer
against stomach
hyaluronate against
peptic ulcer
Prior art date
Application number
AT98920684T
Other languages
English (en)
Inventor
Lazlo Szporny
Janos Illes
Judit Matuz
Erzsebet Neszmelyi
Gaborne Forrai
Bela Stefko
Katalin Saghy
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of ATE320814T1 publication Critical patent/ATE320814T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98920684T 1997-04-29 1998-04-28 Verwendung von zinkhyaluronat gegen magengeschwür ATE320814T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9700826A HU225991B1 (en) 1997-04-29 1997-04-29 Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer

Publications (1)

Publication Number Publication Date
ATE320814T1 true ATE320814T1 (de) 2006-04-15

Family

ID=89995068

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98920684T ATE320814T1 (de) 1997-04-29 1998-04-28 Verwendung von zinkhyaluronat gegen magengeschwür

Country Status (26)

Country Link
US (1) US6656921B1 (de)
EP (1) EP1017403B1 (de)
JP (1) JP2001522361A (de)
KR (1) KR100572190B1 (de)
CN (1) CN1126548C (de)
AT (1) ATE320814T1 (de)
BG (1) BG64458B1 (de)
BR (1) BR9809354A (de)
CA (1) CA2286756C (de)
CZ (1) CZ297317B6 (de)
DE (1) DE69833937T2 (de)
DK (1) DK1017403T3 (de)
EA (1) EA002134B1 (de)
EE (1) EE04953B1 (de)
ES (1) ES2259813T3 (de)
HU (1) HU225991B1 (de)
IL (1) IL132214A0 (de)
NO (1) NO328313B1 (de)
NZ (1) NZ500978A (de)
PL (1) PL189526B1 (de)
PT (1) PT1017403E (de)
SK (1) SK284864B6 (de)
TW (1) TW501927B (de)
UA (1) UA62964C2 (de)
WO (1) WO1998048815A1 (de)
ZA (1) ZA983626B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
ITPD980168A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
AU2006287321B2 (en) * 2005-09-09 2011-09-29 Bally Gaming, Inc. Wagering game system with community gaming system
CN100355790C (zh) * 2005-11-04 2007-12-19 山东福瑞达生物化工有限公司 一种透明质酸锌的制备方法
CN1329414C (zh) * 2005-12-02 2007-08-01 凌沛学 透明质酸铋钾及其制备方法和应用
CN100348621C (zh) * 2005-12-02 2007-11-14 凌沛学 透明质酸铋及其制备方法和应用
CN101023961B (zh) * 2006-02-23 2010-07-21 山东省生物药物研究院 一种含透明质酸钠和锌盐的药物组合物
ITMI20061132A1 (it) * 2006-06-13 2007-12-14 Sinclair Pharmaceuticals Ltd Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) * 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US20110166099A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
ES2388281B1 (es) * 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
WO2013129577A1 (ja) * 2012-03-01 2013-09-06 キユーピー株式会社 ＴＧＦ－β発現促進経口剤、痛み物質産生抑制経口剤及び浮腫抑制経口剤
JPWO2015076294A1 (ja) * 2013-11-22 2017-03-16 キユーピー株式会社 薬剤の副作用である胃潰瘍の発症抑制方法、および胃潰瘍発症が抑制された経口薬剤組成物ならびにその製造方法
CN104262499A (zh) * 2014-09-03 2015-01-07 佐源集团有限公司 一种低聚果糖锌及含有低聚果糖锌的口服液
CN108051553A (zh) * 2017-12-29 2018-05-18 武汉轻工大学 一种仔猪肠道功能保护剂的筛选方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
AU600483B2 (en) * 1986-03-14 1990-08-16 Bio-Technology General Corporation Heavy metal salts of hyaluronic acid
HU203372B (en) * 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
US5472950A (en) 1989-02-24 1995-12-05 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing cobalt hyaluronic acid complex
US6458774B1 (en) * 1989-02-24 2002-10-01 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing hyaluronic acid associates and a process for preparing same
JPH0648950A (ja) * 1992-07-30 1994-02-22 Taito Kk 抗潰瘍剤
HU225329B1 (en) * 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer

Also Published As

Publication number Publication date
DE69833937T2 (de) 2007-06-06
EA199900983A1 (ru) 2000-08-28
CN1126548C (zh) 2003-11-05
CZ382799A3 (cs) 2000-03-15
ZA983626B (en) 1998-11-05
KR100572190B1 (ko) 2006-04-18
CN1254285A (zh) 2000-05-24
DK1017403T3 (da) 2006-07-31
EE04953B1 (et) 2008-02-15
BR9809354A (pt) 2000-07-04
SK284864B6 (sk) 2006-01-05
UA62964C2 (en) 2004-01-15
HU9700826D0 (en) 1997-06-30
HK1025250A1 (en) 2000-11-10
ES2259813T3 (es) 2006-10-16
EE9900470A (et) 2000-06-15
BG103822A (en) 2000-04-28
HU225991B1 (en) 2008-02-28
NZ500978A (en) 2001-05-25
CZ297317B6 (cs) 2006-11-15
BG64458B1 (bg) 2005-03-31
EP1017403B1 (de) 2006-03-22
TW501927B (en) 2002-09-11
WO1998048815A1 (en) 1998-11-05
IL132214A0 (en) 2001-03-19
PL189526B1 (pl) 2005-08-31
NO995229D0 (no) 1999-10-26
NO328313B1 (no) 2010-01-25
SK146899A3 (en) 2000-06-12
HUP9700826A1 (hu) 1998-12-28
PL336482A1 (en) 2000-06-19
DE69833937D1 (de) 2006-05-11
US6656921B1 (en) 2003-12-02
NO995229L (no) 1999-12-22
JP2001522361A (ja) 2001-11-13
PT1017403E (pt) 2006-07-31
EP1017403A1 (de) 2000-07-12
CA2286756C (en) 2008-02-19
KR20010020413A (ko) 2001-03-15
EA002134B1 (ru) 2001-12-24
CA2286756A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
ATE320814T1 (de) Verwendung von zinkhyaluronat gegen magengeschwür
TR199801315T2 (xx) X sendromunun tedavisi i�in bir ppar-alpha ve ppar-gamma antagonistinin kullan�lmas�.
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
IL113812A0 (en) Copolymer-1, pharmaceutical compositions containing it and its use
ATE185066T1 (de) Lösung zur verwendung gegen den pilzbefall von nägeln
BG103251A (bg) Оксадиазоли, методи за получаването им и приложението им като лекарствени средства
ATE234867T1 (de) Reaktionsprodukte von hyaluronsäure und natürlichen aminosäuren sowie deren verwendung in kosmetischen und pharmazeutischen zusammensetzungen
NO924619D0 (no) (+)-alfa-(2,3-dimetoksyfenyl)-1-(2-(4-fluorfenyl)ethyl)-4-piperidinmetanol
ATE285219T1 (de) Rekombinante haarbehandlungsmittel
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
ATE413179T1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
DE69535976D1 (de) Heilung von Wunden oder fibrotischen Krankheiten unter Verwendung von wenigstens einem Agens gegen einen Wachstumsfaktor
ATE254922T1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
RU94044453A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей
PT615751E (pt) Utilizacao de antagonistas de taquinina no tratamento da emese
ATE289808T1 (de) Caroteinoid-nicotinamid-zink zusammensetzungen und verfahren zur behandlung unter verwendung derselben
DE59603219D1 (de) Wasserlösliche oder wasserdispergierbare Pfropfpolymere, ihre Herstellung und ihre Verwendung
BG101138A (en) The use of glyceryltriacetate for the treatment of onychomycosis
BG104232A (bg) Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства
SE9504662D0 (sv) New compounds
GB9505082D0 (en) Medicament
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
DE69431187D1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1017403

Country of ref document: EP